- Home
- HIX vs AMRN Comparison
HIX vs AMRN Comparison
Compare HIX & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
HOLD
Current Price
$14.35
Company Overview
Basic Information| Metric | HIX | AMRN |
|---|---|---|
| Founded | 1998 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.6M | 339.8M |
| IPO Year | N/A | 1993 |
Fundamental Metrics
Financial Performance| Metric | HIX | AMRN |
|---|---|---|
| Price | $4.18 | $14.35 |
| Analyst Decision | | Strong Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 449.5K | 83.8K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 13.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $226,733,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.16 | $7.08 |
| 52 Week High | $5.08 | $20.90 |
Technical Indicators
Market Signals| Indicator | HIX | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 46.58 | 33.29 |
| Support Level | $4.14 | $15.36 |
| Resistance Level | $4.19 | $16.65 |
| Average True Range (ATR) | 0.04 | 0.78 |
| MACD | 0.00 | -0.14 |
| Stochastic Oscillator | 57.14 | 16.90 |
Price Performance
Historical Comparison HIX
AMRN
About HIX Western Asset High Income Fund II Inc.
Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its investment objective is to maximize current income by investing at least 80% of its net assets and borrowings for investment purposes in high-yield debt securities.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.